It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt. An FDA advisory committee ...

Find the latest Lexicon Pharmaceuticals, Inc. (LXRX) stock quote, history, news and other vital information to help you with your stock trading and investing.

This file contains two lexicons at two different borderline (B) values: B=1 and B=2. Each of our two lexicons, VERY-NEG and VERY-POS: 1- VERY-NEG which consists of a list of the most negative words ...

As of 10:36:16 a.m. EST. Market Open.